US replaces head of agency overseeing coronavirus drugs, vaccines

Medical staff, wearing protective suits and face masks, work in an intensive care unit for coronavirus disease (COVID-19) patients at the Franco-Britannique hospital in Levallois-Perret near Paris as the spread of the coronavirus disease continues in France, April 15, 2020.

(photo credit: REUTERS)
The U.S. Department of Health and Human Services said on Tuesday it has replaced Rick Bright as director of a key U.S. agency charged with developing drugs and vaccines for COVID-19.
Bright, who was director of the Biomedical Advanced Research and Development Authority (BARDA) since 2016, has been moved to a new public-private partnership under the National Institutes of Health announced last week, according to a Health and Human Services representative. BARDA serves under the HHS Office of the Assistant Secretary for Preparedness and Response.
Under Bright's leadership, BARDA recently announced nearly $1 billion in support of vaccine manufacturing efforts by Moderna and Johnson & Johnson.
Bright, an expert in vaccines and therapeutics, will be replaced by Gary Disbrow, his former deputy, who will serve as acting director of BARDA. The change was first reported by STAT news.



Follow us on twitter (ajuede.com) or on Instagram (ajuedeman) for details of the global situation presently.

Comments

Popular posts from this blog

Dr. Vladimir Zelenko has now treated 699 coronavirus patients with 100% success

ORIGIN OF THE AKAN

GARDEN OF EDEN FOUND IN AFRICA

THE HISTORY AND ORIGIN OF THE ZULU PEOPLE

BRIEF HISTORY OF NKALAHA.

FIVE WAYS A WIFE CAN REST HER HUSBAND ON HER

MYSTERY OF IGBO COSMOLOGY

THE ORIGIN AND HISTORY OF UDI by Onyeji Nnaji

THE ORIGIN AND HISTORY OF NSUKKA by Onyeji Nnaji

ETHIOPIA:THE OLDEST PEOPLE IN THE MIDDLE EAST